A Closer Look at 4 Analyst Recommendations For Silk Road Medical
Portfolio Pulse from Benzinga Insights
Four analysts have recently shared their evaluations of Silk Road Medical (NASDAQ:SILK), with a mix of bullish and bearish perspectives. The average 12-month price target has increased to $24.0 from $22.0. Analysts have adjusted their ratings and price targets, reflecting their reactions to recent developments.
July 17, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have mixed views on Silk Road Medical, with the average 12-month price target increasing to $24.0 from $22.0. Recent ratings include 'Hold' and 'Neutral' with price targets ranging from $20.00 to $27.50.
The increase in the average price target from $22.0 to $24.0 suggests a positive outlook from analysts. Despite mixed ratings, the upward revision in price targets indicates potential short-term gains for SILK.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100